Claros Demonstrates ≥99.99% PFAS Destruction in Groundwater from MPCA Lake Elmo Site

ClarosTechUV™ delivers commercial-scale performance in complex remediation conditions using PFAS concentrate from Lake Elmo Minnesota site…

Spring Health Named to TIME’s List of the TIME100 Most Influential Companies of 2026

The lifelong mental health platform also named one of TIME’s 10 Most Influential Wellness Companies of…

BLUE CROSS BLUE SHIELD OF MASSACHUSETTS’ INNOVATIVE DIGITAL TOOL TO STREAMLINE PREAPPROVALS DOUBLES IN USE IN A YEAR

Tool removes the need for faxes and phone calls and is being utilized ~15,000 times a…

Bambusa Therapeutics Completes Patient Enrollment in the Phase 1b/2a Trial Evaluating BBT001 as a Treatment for Atopic Dermatitis

– Bambusa’s lead product candidate, BBT001 is a next-generation long-acting bispecific antibody targeting two clinically and…

Genprex Receives Patent Grant from The Israel Patent Office for the Combination of Reqorsa® Gene Therapy and PD-1 Antibodies to Treat Cancer

Strengthens Patent Estate and Expands Protection in Another Target Market AUSTIN, Texas, April 30, 2026 /PRNewswire/…

Don’t Let Ticks Limit Time Outdoors: Know the Preventive Measures to Take

Tick Awareness Week spotlights the risks associated with tick bites and tips to keep people safe…

Optimum Nutrition Introduces New Convenient Formats to Power Everyday Performance

New formats acrosscreatine and protein deliver convenient, trusted support for strength, recovery and everyday routines DOWNERS…

Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation

Presentation and Q&A session scheduled for post-market on Thursday, May 7, 2026 BOSTON, April 30, 2026…

START Research Expands Clinical Leadership with Appointment of Dr. Neel Belani as Clinical Investigator at START New Jersey

Strengthening clinical research capabilities in one of the nation’s most densely populated and high-opportunity oncology markets…

Endometriosis Imaging Study Published in The Lancet Obstetrics, Gynaecology & Women’s Health Highlights 99mTc-maraciclatide as a Promising Diagnostic and Monitoring Tool

LONDON, April 30, 2026 /PRNewswire/ –Serac Healthcare Limited (‘Serac Healthcare’ or ‘the Company’), a clinical radiopharmaceutical…